Management of Myelodysplastic Syndromes: A Focus on Supportive Care

EP. 1: Understanding MDS Disease Characteristics and Progression

March 8th 2016

EP. 2: Classification and Prognosis in MDS

March 8th 2016

EP. 3: Factors to Consider in the Initial Treatment of MDS

March 8th 2016

EP. 4: Choosing Lenalidomide vs ESAs in Del 5q MDS

March 8th 2016

EP. 5: Transfusion Dependence in MDS: The Risk for Iron Overload

March 8th 2016

EP. 6: Monitoring Iron Levels in Transfusion-Dependent MDS

March 8th 2016

EP. 7: How Iron Accumulation Occurs in MDS

March 8th 2016

EP. 8: Negative Effects Associated with Iron Overload

March 8th 2016

EP. 9: Preventing and Diagnosing Iron Overload

March 8th 2016

EP. 10: The Impact of Excess Iron on Cardiac Function in MDS

March 8th 2016

EP. 11: The Role of Iron Chelation Therapy in Patients with MDS

March 8th 2016

EP. 12: Appropriate Use of Iron Chelators in MDS

March 8th 2016

EP. 13: MDS and Iron Overload: An Argument for Iron Chelation Therapy

March 8th 2016

EP. 14: Iron Chelation Therapy Efficacy and Safety in MDS

March 8th 2016

EP. 15: Iron Chelation Therapy in MDS: A Look at the Evidence

March 8th 2016

EP. 16: Factors to Consider in Iron Chelation Therapy

March 8th 2016

EP. 17: When a High-Risk Patient with MDS Might Be Low-Risk

March 8th 2016

EP. 18: The Future Role of Blood Transfusions in MDS

March 8th 2016

EP. 19: MDS: The Current Understanding in Molecular Testing and Biomarkers

March 8th 2016

EP. 20: Progress and Promise in the Treatment of MDS

March 8th 2016